title: Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
authors.forename: U R
authors.initials: UR
authors.lastname: Deotare
authors.forename: A
authors.initials: A
authors.lastname: Vishwabandya
authors.forename: V
authors.initials: V
authors.lastname: Mathews
authors.forename: B
authors.initials: B
authors.lastname: George
authors.forename: A
authors.initials: A
authors.lastname: Srivastava
authors.forename: M
authors.initials: M
authors.lastname: Chandy
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001787:Blood Group Incompatibility; D002066:Busulfan / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000150:complications / Q000628:therapy*; D012074:Remission Induction; D017701:Reticulocyte Count; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous
chemical_list: D000017:ABO Blood-Group System; D000893:Anti-Inflammatory Agents; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D003907:Dexamethasone; D002066:Busulfan